Sobi Q4 and FY 2025 report: Closing the year with significant growth and strategic progress
PR Newswire —
STOCKHOLM, Feb. 5, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter and full year of 2025. Fourth Quarter 2025 Total revenue increased 5 per cent, 16 per cent at CER1, to SEK 7,821 M (7,436) Haematology revenue increased 25...